[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.240.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Li  AA, Cholankeril  G, Cheng  XS,  et al.  Underutilization of hepatitis C virus seropositive donor kidneys in the United States in the current opioid epidemic and direct-acting antiviral era.  Diseases. 2018;6(3):E62. doi:10.3390/diseases6030062PubMedGoogle Scholar
2.
US Department of Health and Human Services. National data: OPTN. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/. Accessed October 31, 2019.
3.
Hart  A, Smith  JM, Skeans  MA,  et al.  OPTN/SRTR 2017 Annual Data Report: Kidney.  Am J Transplant. 2019;19(suppl 2):19-123. doi:10.1111/ajt.15274PubMedGoogle ScholarCrossref
4.
US Department of Health and Human Services. Advancing American Kidney Health. https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf. Published 2019. Accessed July 11, 2019.
5.
Chawla  LS, Eggers  PW, Star  RA, Kimmel  PL.  Acute kidney injury and chronic kidney disease as interconnected syndromes.  N Engl J Med. 2014;371(1):58-66. doi:10.1056/NEJMra1214243PubMedGoogle ScholarCrossref
6.
Nakagawa  K, Tang  JF.  Physiologic response of human brain death and the use of vasopressin for successful organ transplantation.  J Clin Anesth. 2011;23(2):145-148. doi:10.1016/j.jclinane.2009.12.015PubMedGoogle ScholarCrossref
7.
Parikh  CR, Puthumana  J, Shlipak  MG,  et al.  Relationship of kidney injury biomarkers with long-term cardiovascular outcomes after cardiac surgery.  J Am Soc Nephrol. 2017;28(12):3699-3707. doi:10.1681/ASN.2017010055PubMedGoogle ScholarCrossref
8.
Belcher  JM, Sanyal  AJ, Peixoto  AJ,  et al; TRIBE-AKI Consortium.  Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.  Hepatology. 2014;60(2):622-632. doi:10.1002/hep.26980PubMedGoogle ScholarCrossref
9.
Dupont  M, Shrestha  K, Singh  D,  et al.  Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure.  Eur J Heart Fail. 2012;14(6):597-604. doi:10.1093/eurjhf/hfs039PubMedGoogle ScholarCrossref
10.
Ishani  A, Xue  JL, Himmelfarb  J,  et al.  Acute kidney injury increases risk of ESRD among elderly.  J Am Soc Nephrol. 2009;20(1):223-228. doi:10.1681/ASN.2007080837PubMedGoogle ScholarCrossref
11.
Coca  SG, Singanamala  S, Parikh  CR.  Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.  Kidney Int. 2012;81(5):442-448. doi:10.1038/ki.2011.379PubMedGoogle ScholarCrossref
12.
Chawla  LS, Kimmel  PL.  Acute kidney injury and chronic kidney disease: an integrated clinical syndrome.  Kidney Int. 2012;82(5):516-524. doi:10.1038/ki.2012.208PubMedGoogle ScholarCrossref
13.
Puthumana  J, Hall  IE, Reese  PP,  et al.  YKL-40 associates with renal recovery in deceased donor kidney transplantation.  J Am Soc Nephrol. 2017;28(2):661-670. doi:10.1681/ASN.2016010091PubMedGoogle ScholarCrossref
14.
Wilk  AR, Beck  J, Kucheryavaya  AY. The Kidney Allocation System (KAS): the first two years. https://unos.org/wp-content/uploads/unos/KAS_First-two-years_041917.pdf. Accessed June 27, 2019.
15.
OPTN: Organ Procurement and Transplantation Network. Organ Procurement and Transplantation Network policies. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf. Accessed June 27, 2019.
16.
Moledina  DG, Hall  IE, Thiessen-Philbrook  H,  et al.  Performance of serum creatinine and kidney injury biomarkers for diagnosing histologic acute tubular injury.  Am J Kidney Dis. 2017;70(6):807-816. doi:10.1053/j.ajkd.2017.06.031PubMedGoogle ScholarCrossref
17.
Hall  IE, Akalin  E, Bromberg  JS,  et al.  Deceased-donor acute kidney injury is not associated with kidney allograft failure.  Kidney Int. 2019;95(1):199-209. doi:10.1016/j.kint.2018.08.047PubMedGoogle ScholarCrossref
18.
Hall  IE, Schröppel  B, Doshi  MD,  et al.  Associations of deceased donor kidney injury with kidney discard and function after transplantation.  Am J Transplant. 2015;15(6):1623-1631. doi:10.1111/ajt.13144PubMedGoogle ScholarCrossref
19.
Anil Kumar  MS, Khan  SM, Jaglan  S,  et al.  Successful transplantation of kidneys from deceased donors with acute renal failure: three-year results.  Transplantation. 2006;82(12):1640-1645. doi:10.1097/01.tp.0000250908.62948.8fPubMedGoogle ScholarCrossref
20.
Rodrigo  E, Miñambres  E, Piñera  C,  et al.  Using RIFLE criteria to evaluate acute kidney injury in brain-deceased kidney donors.  Nephrol Dial Transplant. 2010;25(5):1531-1537. doi:10.1093/ndt/gfp622PubMedGoogle ScholarCrossref
21.
Kolonko  A, Chudek  J, Pawlik  A, Wilk  J, Jałowiecki  P, Więcek  A.  Acute kidney injury before organ procurement is associated with worse long-term kidney graft outcome.  Transplant Proc. 2011;43(8):2871-2874. doi:10.1016/j.transproceed.2011.07.017PubMedGoogle ScholarCrossref
22.
Farney  AC, Rogers  J, Orlando  G,  et al.  Evolving experience using kidneys from deceased donors with terminal acute kidney injury.  J Am Coll Surg. 2013;216(4):645-655. doi:10.1016/j.jamcollsurg.2012.12.020PubMedGoogle ScholarCrossref
23.
Klein  R, Galante  NZ, de Sandes-Freitas  TV, de Franco  MF, Tedesco-Silva  H, Medina-Pestana  JO.  Transplantation with kidneys retrieved from deceased donors with acute renal failure.  Transplantation. 2013;95(4):611-616. doi:10.1097/TP.0b013e318279153cPubMedGoogle ScholarCrossref
24.
Jacobi  J, Rebhan  D, Heller  K,  et al.  Donor acute kidney injury and short-term graft outcome in renal transplantation.  Clin Transplant. 2014;28(10):1131-1141. doi:10.1111/ctr.12425PubMedGoogle ScholarCrossref
25.
Yu  CC, Ho  HC, Yu  TM,  et al.  Kidneys from standard-criteria donors with different severities of terminal acute kidney injury.  Transplant Proc. 2014;46(10):3335-3338. doi:10.1016/j.transproceed.2014.11.002PubMedGoogle ScholarCrossref
26.
Benck  U, Schnuelle  P, Krüger  B,  et al.  Excellent graft and patient survival after renal transplantation from donors after brain death with acute kidney injury: a case-control study.  Int Urol Nephrol. 2015;47(12):2039-2046. doi:10.1007/s11255-015-1127-5PubMedGoogle ScholarCrossref
27.
Kayler  LK, Garzon  P, Magliocca  J,  et al.  Outcomes and utilization of kidneys from deceased donors with acute kidney injury.  Am J Transplant. 2009;9(2):367-373. doi:10.1111/j.1600-6143.2008.02505.xPubMedGoogle ScholarCrossref
28.
Heilman  RL, Smith  ML, Smith  BH,  et al.  Long-term outcomes following kidney transplantation from donors with acute kidney injury.  Transplantation. 2019;103(9):e263-e272. doi:10.1097/TP.0000000000002792PubMedGoogle ScholarCrossref
29.
Heilman  RL, Smith  ML, Kurian  SM,  et al.  Transplanting kidneys from deceased donors with severe acute kidney injury.  Am J Transplant. 2015;15(8):2143-2151. doi:10.1111/ajt.13260PubMedGoogle ScholarCrossref
30.
Jadloweic  C, Kumar  A, Srinivasan  A,  et al.  Impact of donor acute kidney injury on the outcome of graft delayed graft function  [abstract B137].  Am J Transpl. 2019;19(suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-donor-acute-kidney-injury-on-the-outcome-of-graft-delayed-graft-function/. Accessed October 15, 2019.Google Scholar
31.
Potluri  VS, Parikh  CR, Hall  IE,  et al.  Validating early post-transplant outcomes reported for recipients of deceased donor kidney transplants.  Clin J Am Soc Nephrol. 2016;11(2):324-331. doi:10.2215/CJN.06950615PubMedGoogle ScholarCrossref
32.
Rao  PS, Schaubel  DE, Guidinger  MK,  et al.  A comprehensive risk quantification score for deceased donor kidneys: the Kidney Donor Risk Index.  Transplantation. 2009;88(2):231-236. doi:10.1097/TP.0b013e3181ac620bPubMedGoogle ScholarCrossref
33.
Organ Procurement and Transplantation Network. A guide to calculating and interpreting the Kidney Donor Profile Index (KCPI). https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf. Accessed October 15, 2019.
34.
World Medical Association.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.  JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053PubMedGoogle ScholarCrossref
35.
Khwaja  A.  KDIGO clinical practice guidelines for acute kidney injury.  Nephron Clin Pract. 2012;120(4):c179-c184. doi:10.1159/000339789PubMedGoogle Scholar
36.
Levey  AS, Stevens  LA, Schmid  CH,  et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).  A new equation to estimate glomerular filtration rate.  Ann Intern Med. 2009;150(9):604-612. doi:10.7326/0003-4819-150-9-200905050-00006PubMedGoogle ScholarCrossref
37.
Austin  PC.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.  Stat Med. 2014;33(7):1242-1258. doi:10.1002/sim.5984PubMedGoogle ScholarCrossref
38.
Austin  PC.  An introduction to propensity score methods for reducing the effects of confounding in observational studies.  Multivariate Behav Res. 2011;46(3):399-424. doi:10.1080/00273171.2011.568786PubMedGoogle ScholarCrossref
39.
Austin  PC.  Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.  Commun Stat Simul Comput. 2009;38(6):1228-1234. doi:10.1080/03610910902859574Google ScholarCrossref
40.
Lin  DY, Wei  LJ, Ying  Z.  Checking the Cox model with cumulative sums of martingale-based residuals.  Biometrika. 1993;80(3):557. doi:10.1093/biomet/80.3.557Google ScholarCrossref
41.
Lin  DY, Wei  LJ.  The robust inference for the Cox proportional hazards model.  J Am Stat Assoc. 1989;84(408):1074-1078. doi:10.1080/01621459.1989.10478874Google ScholarCrossref
42.
Chow SC, Shao J, Wang H. Sample Size Calculations in Clinical Research. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2008.
43.
Schoenfeld  DA.  Sample-size formula for the proportional-hazards regression model.  Biometrics. 1983;39(2):499-503. doi:10.2307/2531021PubMedGoogle ScholarCrossref
44.
Xu  S, Ross  C, Raebel  MA, Shetterly  S, Blanchette  C, Smith  D.  Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.  Value Health. 2010;13(2):273-277. doi:10.1111/j.1524-4733.2009.00671.xPubMedGoogle ScholarCrossref
45.
Health Resources & Services Administration. Map services. https://data.hrsa.gov/maps/services. Accessed June 27, 2019.
46.
Zheng  YT, Chen  CB, Yuan  XP, Wang  CX.  Impact of acute kidney injury in donors on renal graft survival: a systematic review and meta-analysis.  Ren Fail. 2018;40(1):649-656. doi:10.1080/0886022X.2018.1535982PubMedGoogle ScholarCrossref
47.
Siedlecki  A, Irish  W, Brennan  DC.  Delayed graft function in the kidney transplant.  Am J Transplant. 2011;11(11):2279-2296. doi:10.1111/j.1600-6143.2011.03754.xPubMedGoogle ScholarCrossref
48.
Boffa  C, van de Leemkolk  F, Curnow  E,  et al.  Transplantation of kidneys from donors with acute kidney injury: friend or foe?  Am J Transplant. 2017;17(2):411-419. doi:10.1111/ajt.13966PubMedGoogle ScholarCrossref
49.
Stokfisz  K, Ledakowicz-Polak  A, Zagorski  M, Zielinska  M.  Ischaemic preconditioning: current knowledge and potential future applications after 30 years of experience.  Adv Med Sci. 2017;62(2):307-316. doi:10.1016/j.advms.2016.11.006PubMedGoogle ScholarCrossref
50.
Tosoc-Haskell  H, Sisaithong  K, Carrico  R.  The Collaborative Improvement and Innovation Network project to drive quality improvement.  Curr Opin Organ Transplant. 2019;24(1):73-81. doi:10.1097/MOT.0000000000000596PubMedGoogle ScholarCrossref
51.
US Department of Health and Human Services. Hospitals chosen for second phase of COIIN pilot. https://optn.transplant.hrsa.gov/news/hospitals-chosen-for-second-phase-of-coiin-pilot/. Accessed July 11, 2019.
52.
Stewart  D, Rosendale  J, McGehee  H,  et al. The influential yet highly variable role of biopsy findings on kidney offer acceptance decisions: an organ offer simulation study [abstract D361]. Am J Transpl. 2019;19(suppl 3). https://atcmeetingabstracts.com/abstract/the-influential-yet-highly-variable-role-of-biopsy-findings-on-kidney-offer-acceptance-decisions-an-organ-offer-simulation-study/. Accessed October 15, 2019.
53.
Husain  SA, King  KL, Pastan  S,  et al.  Association between declined offers of deceased donor kidney allograft and outcomes in kidney transplant candidates.  JAMA Netw Open. 2019;2(8):e1910312. doi:10.1001/jamanetworkopen.2019.10312PubMedGoogle Scholar
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Original Investigation
    Nephrology
    January 8, 2020

    Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival

    Author Affiliations
    • 1Division of Nephrology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
    • 2Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City
    • 3Program of Applied Translational Research, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut
    JAMA Netw Open. 2020;3(1):e1918634. doi:10.1001/jamanetworkopen.2019.18634
    Key Points español 中文 (chinese)

    Question  Is deceased donor acute kidney injury (AKI) associated with recipient graft survival after matching on deceased donor AKI propensity?

    Findings  In this registry-based, propensity scorematched cohort study of deceased donors with and without AKI, deceased donor AKI had no independent association with short-term and long-term recipient graft survival. Recovery and transplantation of AKI kidneys varied by organ procurement organization; most (39 of 58) had high recovery and high discard of AKI kidneys.

    Meaning  This study’s findings suggest that the transplant community should continue to use deceased donor AKI kidneys and consider research to investigate whether currently discarded AKI kidneys can be used more effectively.

    Abstract

    Importance  The shortage of deceased donor kidneys for transplants is an ongoing concern. Prior studies support transplanting kidneys from deceased donors with acute kidney injury (AKI), but those investigations have been subject to selection bias and small sample sizes. Current allocation practices of AKI kidneys in the United States are not well characterized.

    Objectives  To evaluate the association of deceased donor AKI with recipient graft survival and to characterize recovery and discard practices for AKI kidneys by organ procurement organizations.

    Design, Setting, and Participants  Registry-based, propensity scorematched cohort study from January 1, 2010, to December 31, 2013, in the United States. The dates of analysis were March 1 to November 1, 2019. From 2010 to 2013, a total of 6832 deceased donors with AKI and 15 310 deceased donors without AKI had at least 1 kidney transplanted. This study used a 1:1, propensity scorematched analysis to match deceased donors with AKI to deceased donors without AKI and investigated outcomes in their corresponding kidney recipients.

    Exposure  Deceased donor AKI, defined as at least 50% or 0.3-mg/dL increase in terminal serum creatinine level from admission.

    Main Outcomes and Measures  Recipients were assessed for the time to death-censored graft failure and the following secondary outcomes: delayed graft function, primary nonfunction, and the time to all-cause graft failure.

    Results  Ninety-eight percent (6722 of 6832) of deceased donors with AKI were matched to deceased donors without AKI. The mean (SD) age of the 13 444 deceased donors was 40.4 (14.4) years, and 63% (8529 of 13 444) were male. A total of 25 323 recipients were analyzed (15 485 [61%] were male), and their mean (SD) age was 52.0 (14.7) years. Recipients were followed up for a median of 5 (interquartile range, 4-6) years. Deceased donor AKI status had no association with death-censored graft failure (hazard ratio, 1.01; 95% CI, 0.95-1.08) or all-cause graft failure (hazard ratio, 0.97; 95% CI, 0.93-1.02). The results were consistent after examining by AKI stage and adjusting for recipient and transplant characteristics. More recipients of AKI kidneys developed delayed graft function (29% vs 22%, P < .001). Few recipients (120 of 25 323 [0.5%]) developed primary nonfunction regardless of deceased donor AKI status. Recovery and transplantation of AKI kidneys varied by organ procurement organization; most (39 of 58) had high recovery and high discard of AKI kidneys.

    Conclusions and Relevance  Deceased donor AKI kidneys transplanted in the study period had recipient graft survival comparable to that of non-AKI kidneys. This study’s findings suggest that the transplant community should evaluate whether currently discarded AKI kidneys from donors without substantial comorbidities can be used more effectively.

    ×